AKT1 and prostate cancer: PTEN inactivation results in prostate intraepithelial neoplasia (PIN) by activating PI3K/AKT signaling in genetically engineered mouse models, in which prostate cancer has a long latency to progress to high-grade adenocarcinoma, with metastasis occurring rarely (6–8).